Dear Colleague,

One of the most important factors when examining a possible therapy or instrument is whether it can effectively treat a specific disease. During the development of cancer therapies, novel biomarkers are being discovered and used with far-reaching capabilities, including increased risk management and regulatory approval.

GTCbio's 2nd Oncology Biomarkers conference on January 19-20, 2008 in Miami, FL (http://gtcbio.com/conferenceDetails.aspx?id=142) will provide an extensive look at new and innovative techniques for discovering and validating biomarkers. Challenges to biomarker validation will be examined in depth, including regulatory perspectives on development and qualification and reimbursement strategies, as will the clinical application of oncology biomarkers and enabling biomarkers in cancer drug development. Sign up now as space is limited!

Lukas Almer, Development Sciences, Genentech, Inc.
Rebecca Bagley, Senior Scientist, Genzyme Corporation
Stephan Barnhill, Chairman & CEO, Health Discovery Corporation
Christopher Foster, M.D., Ph.D., Professor of Pathology, University of Liverpool
Herbert Fritsche, Chief of Clinical Chemistry, MD Anderson Cancer Center
Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center
Srinivasan Krishnamoorthy, Harvard Medical School (invited)
Thomas Li, Senior Director, Technology Management , Roche
Stephan Little, CEO, DSX Diagnostics (invited)
Andrey Loboda, Oncology Molecular Profiling, Merck & Co.
Cathy Lofton-Day, VP, Molecular Biology, Diagnostics, Epigenomics
Ian McCaffery, Director, Amgen
Scott Patterson, Executive Director, Medical Sciences, Amgen
Henry Rodriguez, Director, Clinical Proteomic Technologies for Cancer, NIH/NCI
Craig Webb, Dir., Program of Translational Medicine, Van Andel Research Inst.
Jeff Waring, Group Leader, Neuroscience Discovery, Abbott Laboratories
Yan Xiao, Principal Investigator, NIST

Click here for a Full Speaker List

Refer a friend and win! If you refer this conference to any of your colleagues and they register to attend, you will receive $50 for every person that signs up. Once you forward the conference information to your colleagues, simply send a list of their names and contact information and the conference you are referring to infogtcbio@gtcbio.com and we will keep record until your colleague signs up!